Terje Andersen

Terje Andersen (born 4 March 1952) is a former speed skater and president of the Norwegian Skating Association. Andersen was a typical middle distance skater, his best achievement being one bronze medal from the 1980 Winter Olympics of Lake Placid.

Andersen participated several times in the World Sprint Championships, finishing fourth in 1981, and sixth in 1978. His best placing in an allround championships is a twelfth place at the World Championships of Oslo in 1975.

He represented Tønsberg TF and Holmestrand og Botne SK. He was president of the Norwegian Skating Association from 1997 to 1999, and again in 2003 to 2007. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Terje Andersen', query time: 0.02s Refine Results
  1. 1
    Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn

    Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn by Johannes Reusch, Jan Terje Andersen, Ulrich Rant, Tilman Schlothauer

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation

    Identification of a direct interaction between the Fab domains of IgG antibodies and human FcRn upon IgG-FcRn complex formation by Esben Trabjerg, Jeannette Nilsen, Torleif Tollefsrud Gjølberg, Jan Terje Andersen, Alexander Leitner, Kasper D. Rand

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Risk factors for rectal bleeding in prostate cancer after radiotherapy with a validation of current rectal dose constraints

    Risk factors for rectal bleeding in prostate cancer after radiotherapy with a validation of current rectal dose constraints by Ellen Lund Schaldemose, Christine Vestergaard Madsen, Ahmed Hussein Zedan, Martin Berg, Henrik Dahl Nissen, Terje Andersen, Bjarke Mortensen, Lars Ulrik Fokdal

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end

    Enhanced plasma half-life and efficacy of engineered human albumin-fused GLP-1 despite enzymatic cleavage of its C-terminal end by Jeannette Nilsen, Kristin Hovden Aaen, Sopisa Benjakul, Fulgencio Ruso-Julve, Thomas Uwe Greiner, Daniela Bejan, Maria Stensland, Sachin Singh, Tilman Schlothauer, Inger Sandlie, Jan Terje Andersen

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Assessing developability early in the discovery process for novel biologics

    Assessing developability early in the discovery process for novel biologics by Monica L. Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif T. Gjølberg, Timothy P. Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus R. Liedl, Peter M. Tessier, John McCafferty, Andreas H. Laustsen

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies

    Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies by Frank R. Brennan, J. Ryan Polli, Jean Sathish, Melissa Ramones, Babette Wolf, Tilman Schlothauer, Shirley J. Peters, Curtis C. Maier, Changhua Ji, David L. Wensel, Derrick Witcher, Patricia C. Ryan, T. Scott Manetz, Adriano Flora, Brian Soper, Birgit Fogal, Lindsey Dzielak, Xiaoting Wang, Prathap Nagaraja Shastri, Karen Price, Michael Doyle, Nidhi Sharda, Mary Struthers, Maximilian Brinkhaus, Bianca Balbino, Eric Stefanich, Masaki Honda, Jan Terje Andersen, Shermaine Mitchell-Ryan, David P. Humphreys

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models

    An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models by Aina Karen Anthi, Anette Kolderup, Eline Benno Vaage, Malin Bern, Sopisa Benjakul, Elias Tjärnhage, Fulgencio Ruso-Julve, Kjell-Rune Jensen, Heidrun Elisabeth Lode, Marina Vaysburd, Jeannette Nilsen, Marie Leangen Herigstad, Siri Aastedatter Sakya, Lisa Tietze, Diego Pilati, Mari Nyquist-Andersen, Mirjam Dürkoop, Torleif Tollefsrud Gjølberg, Linghang Peng, Stian Foss, Morten C. Moe, Benjamin E. Low, Michael V. Wiles, David Nemazee, Frode L. Jahnsen, John Torgils Vaage, Kenneth A. Howard, Inger Sandlie, Leo C. James, Gunnveig Grødeland, Fridtjof Lund-Johansen, Jan Terje Andersen

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: